May 03, 2016
Kite Pharma to Report First Quarter 2016 Financial Results on May 9, 2016
Conference Call and Webcast Scheduled for 4:30 PM Eastern Time
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq:KITE) today announced that it will report first quarter 2016 financial results on Monday, May 9, 2016 after market close. The announcement will be followed by a live audio webcast and conference call at 4:30 PM Eastern Time (1:30 PM Pacific Time).
The webcast will be made available on the Company's website at www.kitepharma.com under the Investors tab in the Events and Presentations section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.
Live (U.S. / Canada): (877) 301-8565
Live (International): (678) 562-4240
Confirmation number: 89570152
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160503007013/en/
Kite Pharma, Inc.
VP, Investor Relations
Justin Jackson, 212-213-0006
Source: Kite Pharma, Inc.
News Provided by Acquire Media